{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:31:36Z","timestamp":1790188296609,"version":"4.1.0"},"reference-count":33,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T00:00:00Z","timestamp":1473724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biopharm &amp; Drug Disp"],"published-print":{"date-parts":[[2016,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The aim of this study was to characterize the pharmacokinetics (PK) of propofol in ICU patients undergoing long\u2010term sedation and to assess the influence of routinely collected covariates on the PK parameters. Propofol concentration\u2013time profiles were collected from 29 patients. Non\u2010linear mixed\u2010effects modelling in NONMEM 7.2 was used to analyse the observed data. The propofol pharmacokinetics was best described with a three\u2010compartment disposition model. Non\u2010parametric bootstrap and a visual predictive check were used to evaluate the adequacy of the developed model to describe the observations. The typical value of the propofol clearance (1.46\u00a0l\/min) approximated the hepatic blood flow. The volume of distribution at steady state was high and was equal to 955.1\u00a0l, which is consistent with other studies involving propofol in ICU patients. There was no statistically significant covariate relationship between PK parameters and opioid type, SOFA score on the day of admission, APACHE II, predicted death rate, reason for ICU admission (sepsis, trauma or surgery), gender, body weight, age, infusion duration and C\u2010reactive protein concentration. The population PK model was developed successfully to describe the time\u2010course of propofol concentration in ICU patients undergoing prolonged sedation. Despite a very heterogeneous group of patients, consistent PK profiles were observed. Copyright \u00a9 2016 John Wiley &amp; Sons, Ltd.<\/jats:p>","DOI":"10.1002\/bdd.2028","type":"journal-article","created":{"date-parts":[[2016,8,24]],"date-time":"2016-08-24T13:06:38Z","timestamp":1472043998000},"page":"456-466","source":"Crossref","is-referenced-by-count":14,"title":["The pharmacokinetics of propofol in ICU patients undergoing long\u2010term sedation"],"prefix":"10.1002","volume":"37","author":[{"given":"Piotr","family":"Smuszkiewicz","sequence":"first","affiliation":[{"name":"Department of Anaesthesiology and Intensive Therapy Karol Marcinkowski University of Medical Sciences  ul. Przybyszewskiego 49 60\u2010355 Pozna\u0144 Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2878-3161","authenticated-orcid":false,"given":"Pawe\u0142","family":"Wiczling","sequence":"additional","affiliation":[{"name":"Department of Biopharmacy and Pharmacodynamics Medical University of Gdansk  ul. Hallera 107 80\u2010416 Gda\u0144sk Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Przyby\u0142owski","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Biopharmacy Karol Marcinkowski University of Medical Sciences  ul. Grunwaldzka 6 60\u2010780 Pozna\u0144 Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Borsuk","sequence":"additional","affiliation":[{"name":"Department of Biopharmacy and Pharmacodynamics Medical University of Gdansk  ul. Hallera 107 80\u2010416 Gda\u0144sk Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Trojanowska","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology and Intensive Therapy Karol Marcinkowski University of Medical Sciences  ul. Przybyszewskiego 49 60\u2010355 Pozna\u0144 Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Paterska","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Biopharmacy Karol Marcinkowski University of Medical Sciences  ul. Grunwaldzka 6 60\u2010780 Pozna\u0144 Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Matysiak","sequence":"additional","affiliation":[{"name":"Department of Inorganic and Analytical Chemistry Karol Marcinkowski University of Medical Sciences  ul. Grunwaldzka 6 60\u2010780 Pozna\u0144 Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4950-9759","authenticated-orcid":false,"given":"Zenon","family":"Kokot","sequence":"additional","affiliation":[{"name":"Department of Inorganic and Analytical Chemistry Karol Marcinkowski University of Medical Sciences  ul. Grunwaldzka 6 60\u2010780 Pozna\u0144 Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund","family":"Grze\u015bkowiak","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Biopharmacy Karol Marcinkowski University of Medical Sciences  ul. Grunwaldzka 6 60\u2010780 Pozna\u0144 Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Bienert","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Biopharmacy Karol Marcinkowski University of Medical Sciences  ul. Grunwaldzka 6 60\u2010780 Pozna\u0144 Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,9,13]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cacc.2006.06.002"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-015-3695-3"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200317040-00003"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200108000-00011"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.2004.03745.x"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1734-1140(12)70874-5"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199008000-00004"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-010-9161-5"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100309"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.2007.05055.x"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(87)80394-8"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-011-9255-z"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-2607(98)00098-4"},{"key":"e_1_2_8_15_1","first-page":"69","article-title":"Splanchnic and total body oxygen consumption differences in septic and injured patients","volume":"101","author":"Dahn MS","year":"1987","journal-title":"Surgery"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2003.12.004"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-009-9133-0"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000000165"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-007-0399-9"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.10275"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2008.100"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.1990.tb14743.x"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/68.5.486"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01700659"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200003000-00017"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1734-1140(12)70737-5"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.2009"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2002.129500"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241140-00002"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.2174\/138920111798808248"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.2165\/11318140-000000000-00000"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199805000-00006"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-015-9404-6"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1734-1140(12)70737-5"}],"container-title":["Biopharmaceutics &amp; Drug Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fbdd.2028","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bdd.2028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T14:39:18Z","timestamp":1696603158000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/bdd.2028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,13]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["10.1002\/bdd.2028"],"URL":"https:\/\/doi.org\/10.1002\/bdd.2028","archive":["Portico"],"relation":{},"ISSN":["0142-2782","1099-081X"],"issn-type":[{"value":"0142-2782","type":"print"},{"value":"1099-081X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,13]]}}}